Last reviewed · How we verify

Eflornithine hydrochloride cream — Competitive Intelligence Brief

Eflornithine hydrochloride cream (Eflornithine hydrochloride cream) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Ornithine decarboxylase inhibitor. Area: Dermatology.

phase 3 Ornithine decarboxylase inhibitor Ornithine decarboxylase (ODC) Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Eflornithine hydrochloride cream (Eflornithine hydrochloride cream) — National Skin Centre. Eflornithine inhibits ornithine decarboxylase, an enzyme required for polyamine synthesis, thereby slowing hair growth in facial hirsutism.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Eflornithine hydrochloride cream TARGET Eflornithine hydrochloride cream National Skin Centre phase 3 Ornithine decarboxylase inhibitor Ornithine decarboxylase (ODC)
Eflornithine Topical Eflornithine Topical Khyber Teaching Hospital marketed Ornithine decarboxylase inhibitor Ornithine decarboxylase (ODC)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Ornithine decarboxylase inhibitor class)

  1. Khyber Teaching Hospital · 1 drug in this class
  2. National Skin Centre · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Eflornithine hydrochloride cream — Competitive Intelligence Brief. https://druglandscape.com/ci/eflornithine-hydrochloride-cream. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: